PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to investigate the feasibility and toxicity of using
prostate-specific membrane antigen-positron emission tomography (PSMA-PET) and
multi-parametric magnetic resonance imagining (mpMRI) with PET-MR technology to define
radiotherapy targets, while meeting all the current planning criteria.